BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12005550)

  • 1. Quantitative subcellular secondary ion mass spectrometry (SIMS) imaging of boron-10 and boron-11 isotopes in the same cell delivered by two combined BNCT drugs: in vitro studies on human glioblastoma T98G cells.
    Chandra S; Lorey II DR; Smith DR
    Radiat Res; 2002 Jun; 157(6):700-10. PubMed ID: 12005550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative evaluation of boron neutron capture therapy (BNCT) drugs for boron delivery and retention at subcellular-scale resolution in human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
    Chandra S; Ahmad T; Barth RF; Kabalka GW
    J Microsc; 2014 Jun; 254(3):146-56. PubMed ID: 24684609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative subcellular imaging of boron compounds in individual mitotic and interphase human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
    Chandra S; Tjarks W; Lorey DR; Barth RF
    J Microsc; 2008 Jan; 229(Pt 1):92-103. PubMed ID: 18173648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combined effect of boronophenylalanine and borocaptate in boron neutron capture therapy for SCCVII tumors in mice.
    Ono K; Masunaga S; Suzuki M; Kinashi Y; Takagaki M; Akaboshi M
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):431-6. PubMed ID: 10030272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responses of total and quiescent cell populations in solid tumors to boron and gadolinium neutron capture reaction using neutrons with two different energy spectra.
    Masunaga S; Ono K; Sakurai Y; Suzuki M; Takagaki M; Kobayashi T; Kinashi Y; Akaboshi M
    Jpn J Cancer Res; 1998 Jan; 89(1):81-8. PubMed ID: 9510480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of boron-10 in soft tissue by dynamic secondary ion mass spectrometry.
    Oyedepo AC; Brooke SL; Heard PJ; Day JC; Allen GC; Patel H
    J Microsc; 2004 Jan; 213(1):39-45. PubMed ID: 14678511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of the high-LET radiations from the boron neutron capture [10B(n,α) 7Li] reaction determined for induction of chromosome aberrations and apoptosis in lymphocytes of human blood samples.
    Schmid TE; Canella L; Kudejova P; Wagner FM; Röhrmoser A; Schmid E
    Radiat Environ Biophys; 2015 Mar; 54(1):91-102. PubMed ID: 25428113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular distribution of various boron compounds for use in boron neutron capture therapy.
    Nguyen T; Brownell GL; Holden SA; Teicher BA
    Biochem Pharmacol; 1993 Jan; 45(1):147-55. PubMed ID: 8424808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of fluorine and boron from fluorinated boronophenylalanine in the same cell at organelle resolution by correlative ion microscopy and confocal laser scanning microscopy.
    Chandra S; Kabalka GW; Lorey DR; Smith DR; Coderre JA
    Clin Cancer Res; 2002 Aug; 8(8):2675-83. PubMed ID: 12171900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic secondary ion mass spectrometry analysis of boron from boron neutron capture therapy drugs in co-cultures: single-cell imaging of two different cell types within the same ion microscopy field of imaging.
    Lorey DR; Morrison GH; Chandra S
    Anal Chem; 2001 Aug; 73(16):3947-53. PubMed ID: 11534721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological evaluation of boronated unnatural amino acids as new boron carriers.
    Kabalka GW; Yao ML; Marepally SR; Chandra S
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S374-9. PubMed ID: 19398346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
    Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
    Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
    Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
    Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of borono-phenylalanine-fructose complex (BPA-fr) and borocaptate sodium (BSH) in cancer patients--results from EORTC trial 11001.
    Bendel P; Wittig A; Basilico F; Mauri PL; Sauerwein W
    J Pharm Biomed Anal; 2010 Jan; 51(1):284-7. PubMed ID: 19735988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capillary electrophoresis-electrospray mass spectrometry and HR-ICP-MS for the detection and quantification of 10B-boronophenylalanine (10B-BPA) used in boron neutron capture therapy.
    Pitois A; de las Heras LA; Zampolli A; Menichetti L; Carlos R; Lazzerini G; Cionini L; Salvatori PA; Betti M
    Anal Bioanal Chem; 2006 Feb; 384(3):751-60. PubMed ID: 16372182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of hypoxia-specific cytotoxic bioreductive agent-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.
    Masunaga S; Nagasawa H; Gotoh K; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
    Radiat Med; 2006 Feb; 24(2):98-107. PubMed ID: 16715670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of electroporation on cell killing by boron neutron capture therapy using borocaptate sodium (10B-BSH).
    Ono K; Kinashi Y; Masunaga S; Suzuki M; Takagaki M
    Jpn J Cancer Res; 1998 Dec; 89(12):1352-7. PubMed ID: 10081497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Studies to Define the Cell-Surface and Intracellular Targets of Polyarginine-Conjugated Sodium Borocaptate as a Potential Delivery Agent for Boron Neutron Capture Therapy.
    Fujimura A; Yasui S; Igawa K; Ueda A; Watanabe K; Hanafusa T; Ichikawa Y; Yoshihashi S; Tsuchida K; Kamiya A; Furuya S
    Cells; 2020 Sep; 9(10):. PubMed ID: 32977522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.